Oruka Therapeutics, Inc. (ORKA) — Long-term Investment Intensity
Oruka Therapeutics, Inc. (ORKA) has a Long-term Investment Intensity of 22.1% as of June 2026. Long-term investments of $252.02 Million represent 22.1% of total assets of $1.14 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See ORKA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Oruka Therapeutics, Inc. Long-term Investment Intensity (2024–2025)
This chart shows how Oruka Therapeutics, Inc.'s Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of June 2026, the intensity stands at 22.1%, reflecting long-term investments of $252.02 Million against total assets of $1.14 Billion USD. See Oruka Therapeutics, Inc. defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Oruka Therapeutics, Inc. (2024–2025)
The table below presents the year-by-year Long-term Investment Intensity for Oruka Therapeutics, Inc. from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Oruka Therapeutics, Inc..
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 29.2% | $142.54 Million | $488.62 Million | ▲ +24.6 pp |
| 2024 | 4.6% | $18.07 Million | $396.02 Million | — |